Clinical Trial: Safety and Efficacy of Autologous iNSC-DAP in the Treatment of Parkinson's Disease
Study Status: Completed
Recruit Status: RECRUITING
Condition: Parkinson's Disease
Study Type: INTERVENTIONAL
Official Title: Safety and Efficacy of Autologous Induced Neural Stem Cell-derived Dopaminergic Precursor Cells in the Treatment of Parkinson's Disease
Brief Summary:
This is a phase I, interventional, single arm, open-label, clinical study to evaluate the safety and efficacy of the striatal transplantation of autologous induced neural stem cell-derived DA precursor cells in Parkinson's Disease patients.
Read more